150 related articles for article (PubMed ID: 15773355)
1. [New approach for atrial fibrillation by suppression of renin-angiotensin system].
Kumagai K
Nihon Rinsho; 2005 Mar; 63(3):523-7. PubMed ID: 15773355
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation and atrial fibrosis.
Tan AY; Zimetbaum P
J Cardiovasc Pharmacol; 2011 Jun; 57(6):625-9. PubMed ID: 21633248
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation and renin-angiotensin system.
Serra JL; Bendersky M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
[TBL] [Abstract][Full Text] [Related]
4. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
Kalus JS; Coleman CI; White CM
J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
[TBL] [Abstract][Full Text] [Related]
5. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
Doğan A; Akçay S
Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
[TBL] [Abstract][Full Text] [Related]
6. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
Healey JS; Morillo CA; Connolly SJ
Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials, the renin angiotensin system and atrial fibrillation.
Birnie DH; Gollob M; Healey JS
Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.
Levine MJ; Schweitzer P
Vnitr Lek; 2010 Nov; 56(11):1138-41. PubMed ID: 21247007
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.
Lau YF; Yiu KH; Siu CW; Tse HF
J Hum Hypertens; 2012 Oct; 26(10):563-9. PubMed ID: 22129612
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
Heusch G; Schulz R
Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
[TBL] [Abstract][Full Text] [Related]
11. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
Ducharme A; Schiffrin EL
Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
[TBL] [Abstract][Full Text] [Related]
12. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
Dai SM; Zhang S; Chu JM; Guo YH; Chen KP; Yao Sy
Med Hypotheses; 2007; 69(4):767-72. PubMed ID: 17475415
[TBL] [Abstract][Full Text] [Related]
13. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
[TBL] [Abstract][Full Text] [Related]
15. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
[TBL] [Abstract][Full Text] [Related]
16. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
[TBL] [Abstract][Full Text] [Related]
17. Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results.
Durin O; Pedrinazzi C; Inama G
J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):912-8. PubMed ID: 20729747
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
19. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E
Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613
[TBL] [Abstract][Full Text] [Related]
20. The role of renin angiotensin system blockade in the treatment of atrial fibrillation.
Dilaveris P; Giannopoulos G; Synetos A; Stefanadis C
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):387-403. PubMed ID: 16248831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
